CAS: 183319-69-9 - Erlotinib hydrochloride

Fórmula: C₂₂H₂₄ClN₃O₄

InChI: InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H

Chave InChI: InChIKey=GTTBEUCJPZQMDZ-UHFFFAOYSA-N

SMILES: Cl.C#CC1=CC=CC(=C1)NC=2N=CN=C3C=C(OCCOC)C(OCCOC)=CC32

Sinónimos:

• 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)
• 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride
• 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride
• Cp 358774
• Erlotinib HCl
• Erlotinib Hcl Salt
• Erlotinib, Hydrochloride Salt
• Erlotinib, OS-774
• N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide
• N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4- Hydrochloride
• N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine Hydrochloride
• N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride
• N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
• N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride (1:1)
• N-(4-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride (1:1)
• Osi 774
• Tarceva
• [6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride
• [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine
• quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva

Erlotinib Hydrochloride

CAS: 183319-69-9

• Fórmula: C₂₂H₂₃N₃O₄·HCl
• Pureza: >98.0%(T)(HPLC)
• Cor e Forma: White to Light yellow powder to crystal
• Peso molecular: 429.90

Erlotinib Hydrochloride

CAS: 183319-69-9

Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure

• Fórmula: C₂₂H₂₃N₃O₄·HCl
• Cor e Forma: Pale Yellow Powder
• Peso molecular: 429.14553

4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)

CAS: 183319-69-9

• Fórmula: C₂₂H₂₄ClN₃O₄
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 429.8967

Erlotinib hydrochloride

CAS: 183319-69-9

Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for …

• Fórmula: C₂₂H₂₃N₃O₄·HCl
• Pureza: 99.52% - 99.85%
• Cor e Forma: White Or Off-White Powder
• Peso molecular: 429.9

Erlotinib Hydrochloride Salt

CAS: 183319-69-9

• Fórmula: C₂₂H₂₃N₃O₄·ClH
• Pureza: By hplc: 99.9% by area (Typical Value in Batch COA)
• Cor e Forma: white to off-white crystalline solid
• Peso molecular: 429.90g/mol

Erlotinib hydrochloride

CAS: 183319-69-9

• Fórmula: C₂₂H₂₃N₃O₄·HCl
• Pureza: ≥ 98.0% (dried basis)
• Cor e Forma: White to off-white powder
• Peso molecular: 429.90

Erlotinib HCl

CAS: 183319-69-9

• Fórmula: C₂₂H₂₃N₃O₄·HCl
• Cor e Forma: White To Off-White Solid
• Peso molecular: 393.45 36.46

Erlotinib Hydrochloride

CAS: 183319-69-9

• Fórmula: C₂₂H₂₃N₃O₄·ClH
• Cor e Forma: Neat
• Peso molecular: 429.90

Erlotinib Impurity 95

CAS: 183319-69-9

• Fórmula: C₁₄H₈ClN₃O₂
• Peso molecular: 285.69

Erlotinib Hydrochloride (Tarceva)

CAS: 183319-69-9

Applications Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic. References Moyer, J.D., et al.: …

• Fórmula: C₂₂H₂₃N₃O₄·ClH
• Cor e Forma: White To Light Yellow
• Peso molecular: 429.90

6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride

CAS: 183319-69-9

• Pureza: 97.0%
• Cor e Forma: Solid, Crystalline Powder
• Peso molecular: 429.8999938964844

Tarceva (Erlotinib Hydrochloride)

CAS: 183319-69-9

Applications Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic. References Moyer, J.D., et al.: …

• Fórmula: C₂₂H₂₃N₃O₄·ClH
• Cor e Forma: Neat
• Peso molecular: 429.90

Erlotinib hydrochloride - Bio-X ™

CAS: 183319-69-9

Erlotinib is a drug that is used to treat human malignancies. It is a type …

• Fórmula: C₂₂H₂₃N₃O₄·HCl
• Pureza: Min. 95%
• Cor e Forma: Powder
• Peso molecular: 429.9 g/mol

Erlotinib HCl

CAS: 183319-69-9

Tyrosine kinase inhibitor; affects EGFR receptor; pancreatic cancer treatment

• Fórmula: C₂₂H₂₃N₃O₄·HCl
• Pureza: Min. 98 Area-%
• Cor e Forma: Powder
• Peso molecular: 429.9 g/mol